Viewing Study NCT05201859


Ignite Creation Date: 2025-12-24 @ 2:23 PM
Ignite Modification Date: 2025-12-31 @ 3:33 AM
Study NCT ID: NCT05201859
Status: RECRUITING
Last Update Posted: 2022-05-06
First Post: 2022-01-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Adjuvant Sintilimab Plus Capecitabine in Nasopharyngeal Carcinoma
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module